ABOUT THIS EPISODE
In Part 2 of this two-part “Engaging the Experts” interview, William Zellmer talks with Edward Li and James Stevenson regarding biosimilars, focusing on interchangeability and the integration of biosimilars into the medication-use system.
Faculty:
Edward C. Li, Pharm.D., M.P.H., BCOP, Activity Chair
Associate Professor
Department of Pharmacy Practice
University of New England College of Pharmacy
Portland, Maine
James G. Stevenson, Pharm.D., FASHP
Professor, Department of Clinical Pharmacy
University of Michigan College of Pharmacy
President, Hospital and Health System Services
Visante, Inc.
Ann Arbor, Michigan
C.E. Credits: This activity is not eligible for continuing education credits.
English
United States
IN THIS EPISODE
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SEARCH PAST EPISODES
Search past episodes of ASHP Advantage Podcasts.
OTHER EPISODES IN THIS PODCAST
William Zellmer discusses issues related to improving hyponatremia management in hospitalized patients with Joseph Dasta and Gretchen Brophy. They explore how findings from a hyponatremia registry and disease-based medication-use evaluations of hyponatremia can help identify areas of patient care n…
In Part 1 of this two-part “Engaging the Experts” interview, William Zellmer talks with Edward Li and James Stevenson regarding the status of biosimilars in the European Union and United States.
Faculty:
Edward C. Li, Pharm.D., M.P.H., BCOP, Activity Chair
Associate Professor
Department of Phar…
William Zellmer talks with Susan Cornell and Curtis Triplitt about SGLT2 inhibitors, one of the newest classes of oral diabetes medications. With an increasing number of both oral and injectable medications, the faculty explore how SGLT2 inhibitors fit into clinical practice.
Faculty:
Susan Corn…
William Zellmer talks with Susan Cornell and Curtis Triplitt about SGLT2 inhibitors, one of the newest classes of oral diabetes medications. With an increasing number of both oral and injectable medications, the faculty explore how SGLT2 inhibitors fit into clinical practice.
Faculty:
Susan Corn…
Disclaimer: The podcast and artwork embedded on this page are from ASHP Advantage, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
